Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499421 · ClinicalTrials.gov registry record
Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 23
- Enrollment target
NCT00499421: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00499421 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00499421 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to evaluate a system for localizing (targeting for treatment) the prostate for external beam radiation therapy. The system will be used to locate the prostate before treatment and to measure movement of the prostate during treatment. The data collected with the system will be compared to CT images taken during the course of your radiation therapy treatment. Researchers will try to use this information to verify the performance of the system, which could lead to improved positioning and tracking of the prostate during treatment.
Interventions
- PROCEDURE Computed Tomography (CT) Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2005-09-14 |
| Est. Completion | 2023-01-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00499421
The ClinicalTrials.gov registry entry for NCT00499421 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Computed Tomography (CT) Scan is the first listed.
NCT00499421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00499421 about?
NCT00499421 is a clinical study titled "Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy". The goal of this clinical research study is to evaluate a system for localizing (targeting for treatment) the prostate for external beam radiation therapy. The system will be used to locate the prostate before treatment and to measure movement of the prostate during treatment. The data collected wit...
What is the current status of trial NCT00499421?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2005-09-14. Estimated completion is 2023-01-26.
What interventions are being tested in trial NCT00499421?
The interventions under investigation include: Computed Tomography (CT) Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00499421?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.